Skip to main content
Year archive

IMMUTEP LIMITED — 2010 filings

All 91 regulatory filings released by IMMUTEP LIMITED (IMM) in 2010, sourced directly from the official regulator.

91 Filings
2010 Period
2010 filings (91)
Filing Released Lang
Response to ASX Price Query 3 pages 129.5KB
Regulatory Filings
2010-12-22 English
Appendix 3B 7 pages 100.3KB
Share Issue/Capital Change
2010-12-22 English
Trading Policy 7 pages 122.8KB
Governance Information
2010-12-22 English
PRR TO PRESENT AT DEUTSCHE BANK BioFEST CONFERENCE 34 pages ?Kb
Investor Presentation
2010-12-12 English
Appendix 3B and Section 708A Notice 8 pages ?Kb
Capital/Financing Update
2010-12-09 English
Appendix 3Y x 5 10 pages ?Kb
Director's Dealing
2010-12-09 English
Prima Biomed Investor Update 4 pages ?Kb
Investor Presentation
2010-12-07 English
Amended Constitution 46 pages ?Kb
Governance Information
2010-11-28 English
Chairman`s AGM Address 2 pages ?Kb
AGM Information
2010-11-25 English
AGM Presentation 33 pages ?Kb
AGM Information
2010-11-25 English
Results of Annual General Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2010-11-25 English
Appendix 3B and Section 708A Notice 8 pages ?Kb
Share Issue/Capital Change
2010-11-23 English
Teleconference details for Annual General Meeting 1
AGM Information
2010-11-23 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-11-10 English
Notice of Annual General Meeting/Proxy Form 42 pages ?Kb
AGM Information
2010-10-27 English
Annual Report to shareholders 80 pages ?Kb
Annual Report
2010-10-27 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2010-10-26 English
Appendix 4C - quarterly 9 pages ?Kb
Interim / Quarterly Report
2010-10-24 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-10-21 English
PRR to present at Inaugural Cancer Immunotherapy Conference 23 pages ?Kb
Investor Presentation
2010-10-17 English
Appendix 3X 2 pages ?Kb
Director's Dealing
2010-10-07 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-10-07 English
Prima Biomed Appoints Lucy Turnbull as Chairman 2 pages ?Kb
Board/Management Information
2010-10-06 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-09-30 English
Prima Biomed to list on NASDAQ 2 pages ?Kb
Capital/Financing Update
2010-09-29 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-09-23 English
2010 Annual Report 75 pages ?Kb
Annual Report
2010-09-22 English
2010 Annual Report 76 pages ?Kb
Annual Report
2010-09-22 English
US FDA Grants Orphan Drug Designation Approval for CVac 2 pages ?Kb
Capital/Financing Update
2010-09-19 English
Prima Biomed Investor Update 4 pages ?Kb
Investor Presentation
2010-09-12 English
US Investor Presentation 33 pages ?Kb
Investor Presentation
2010-09-05 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-08-29 English
Preliminary Final Report 18 pages ?Kb
Annual Report
2010-08-26 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-08-22 English
PRR appoints Senior Vice President for CVac clinical program 2 pages ?Kb
Board/Management Information
2010-08-18 English
Licensing Agreement Cripto-1 cancer immunotherapy treatment 2 pages ?Kb
Capital/Financing Update
2010-08-16 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2010-08-10 English
Change of Director`s Interest Notice - AW 2 pages ?Kb
Director's Dealing
2010-08-10 English
Appendix 4C - quarterly 8 pages ?Kb
Interim / Quarterly Report
2010-07-29 English
Letter from Chairman 2 pages ?Kb
Regulatory Filings
2010-07-27 English
Resignation of Director 1 page ?Kb
Board/Management Information
2010-07-26 English
Final Director`s Interest Notice - AG 2 pages ?Kb
Director's Dealing
2010-07-26 English
Initial Director`s Interest Notice x 2 4 pages ?Kb
Director's Dealing
2010-07-26 English
New Board Appointments 2 pages ?Kb
Board/Management Information
2010-07-22 English
First Patient Enrolled on CVac Phase IIb Trial 3 pages ?Kb
Regulatory Filings
2010-07-22 English
Appendix 3B and Section 708A Notice 8 pages ?Kb
Capital/Financing Update
2010-07-21 English
Price Query Response 4 pages ?Kb
Regulatory Filings
2010-07-05 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-06-30 English
Final Director`s Interest Notice - MR 2 pages ?Kb
Director's Dealing
2010-06-27 English
Change in Management Structure 2 pages ?Kb
Board/Management Information
2010-06-24 English
Ceasing to be a substantial holder 4 pages ?Kb
Regulatory Filings
2010-06-22 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-06-21 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-06-14 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-06-07 English
Prima Biomed granted Orphan Drug designation for CVac 2 pages ?Kb
Regulatory Filings
2010-06-02 English
German Fraunhofer Institute Partnership 3 pages ?Kb
Capital/Financing Update
2010-05-26 English
Appendix 3B and s708A 8 pages ?Kb
Capital/Financing Update
2010-05-20 English
US Investor Presentation 22 pages ?Kb
Investor Presentation
2010-05-10 English
Change of Directors Interest - MR 2 pages ?Kb
Director's Dealing
2010-05-06 English
Appendix 3B and Section 708A Notice 8 pages ?Kb
Share Issue/Capital Change
2010-05-05 English
Appendix 3Y - Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-04-29 English
FDA Approval for Dendreon and Dial in for EGM 18 pages ?Kb
Investor Presentation
2010-04-29 English
Results of Extraordinary General Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2010-04-29 English
Prima Biomed appoints new Director to the Board 2 pages ?Kb
Board/Management Information
2010-04-27 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-04-27 English
Initial Director`s Interest Notice - AW 2 pages ?Kb
Director's Dealing
2010-04-27 English
Appendix 4C - quarterly 7 pages ?Kb
Interim / Quarterly Report
2010-04-22 English
Chairman`s Letter 2 pages ?Kb
Investor Presentation
2010-04-20 English
Appendix 3B and s708A Notice 8 pages ?Kb
Share Issue/Capital Change
2010-04-19 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-04-15 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-03-31 English
Latest Presentation 16 pages ?Kb
Investor Presentation
2010-03-28 English
Notice of Meeting 15 pages ?Kb
AGM Information
2010-03-25 English
Appendix 3B and s708A Notice 8 pages ?Kb
Share Issue/Capital Change
2010-03-18 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-03-11 English
EMEA Orphan Medicinal Product Designation 2 pages ?Kb
Capital/Financing Update
2010-03-04 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-03-04 English
Change in substantial holding 4 pages ?Kb
Regulatory Filings
2010-02-28 English
Prima Biomed Completes SPP Short-Fall 2 pages ?Kb
Capital/Financing Update
2010-02-22 English
Appendix 3B and s708A 8 pages ?Kb
Capital/Financing Update
2010-02-22 English
Half Yearly Report and Accounts 20 pages ?Kb
Regulatory Filings
2010-02-21 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-02-08 English
Commencement of CVac Ovarian Cancer Treatment Vaccine Phase 2 pages ?Kb
Capital/Financing Update
2010-02-04 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-01-28 English
Appendix 4C - Quarterly 9 pages ?Kb
Interim / Quarterly Report
2010-01-26 English
Prima BioMed appoints Chief Operating Officer 2 pages ?Kb
Board/Management Information
2010-01-21 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-01-20 English
Appendix 3B and s708A 8 pages ?Kb
Share Issue/Capital Change
2010-01-12 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-01-10 English
Investor Presentation US 8 pages ?Kb
Investor Presentation
2010-01-07 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-01-04 English